181 related articles for article (PubMed ID: 28942152)
1. Relaxin alleviates TGFβ1-induced cardiac fibrosis via inhibition of Stat3-dependent autophagy.
Yuan Y; Zhang Y; Han X; Li Y; Zhao X; Sheng L; Li Y
Biochem Biophys Res Commun; 2017 Dec; 493(4):1601-1607. PubMed ID: 28942152
[TBL] [Abstract][Full Text] [Related]
2. Relaxin modulates cardiac fibroblast proliferation, differentiation, and collagen production and reverses cardiac fibrosis in vivo.
Samuel CS; Unemori EN; Mookerjee I; Bathgate RA; Layfield SL; Mak J; Tregear GW; Du XJ
Endocrinology; 2004 Sep; 145(9):4125-33. PubMed ID: 15155573
[TBL] [Abstract][Full Text] [Related]
3. EphrinB2 Regulates Cardiac Fibrosis Through Modulating the Interaction of Stat3 and TGF-β/Smad3 Signaling.
Su SA; Yang D; Wu Y; Xie Y; Zhu W; Cai Z; Shen J; Fu Z; Wang Y; Jia L; Wang Y; Wang JA; Xiang M
Circ Res; 2017 Sep; 121(6):617-627. PubMed ID: 28743805
[TBL] [Abstract][Full Text] [Related]
4. NLRC5 silencing ameliorates cardiac fibrosis by inhibiting the TGF‑β1/Smad3 signaling pathway.
Zhou H; Yu X; Zhou G
Mol Med Rep; 2017 Sep; 16(3):3551-3556. PubMed ID: 28713900
[TBL] [Abstract][Full Text] [Related]
5. Autophagy inhibition of hsa-miR-19a-3p/19b-3p by targeting TGF-β R II during TGF-β1-induced fibrogenesis in human cardiac fibroblasts.
Zou M; Wang F; Gao R; Wu J; Ou Y; Chen X; Wang T; Zhou X; Zhu W; Li P; Qi LW; Jiang T; Wang W; Li C; Chen J; He Q; Chen Y
Sci Rep; 2016 Apr; 6():24747. PubMed ID: 27098600
[TBL] [Abstract][Full Text] [Related]
6. Relaxin inhibits cardiac fibrosis and endothelial-mesenchymal transition via the Notch pathway.
Zhou X; Chen X; Cai JJ; Chen LZ; Gong YS; Wang LX; Gao Z; Zhang HQ; Huang WJ; Zhou H
Drug Des Devel Ther; 2015; 9():4599-611. PubMed ID: 26316699
[TBL] [Abstract][Full Text] [Related]
7. STAT1/3 and ERK1/2 synergistically regulate cardiac fibrosis induced by high glucose.
Dai B; Cui M; Zhu M; Su WL; Qiu MC; Zhang H
Cell Physiol Biochem; 2013; 32(4):960-71. PubMed ID: 24107317
[TBL] [Abstract][Full Text] [Related]
8. Ryanodine Receptor Type 2 Plays a Role in the Development of Cardiac Fibrosis under Mechanical Stretch Through TGFβ-1.
Ding Z; Yuan J; Liang Y; Wu J; Gong H; Ye Y; Jiang G; Yin P; Li Y; Zhang G; Yang C; Guo J; Chen Z; Wang X; Weng L; Zou Y
Int Heart J; 2017 Dec; 58(6):957-961. PubMed ID: 29162778
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of eIF3a ameliorates cardiac fibrosis by inhibiting the TGF-β1/Smad3 signaling pathway.
Li B; Chen H; Yang X; Wang Y; Qin L; Chu Y
Cell Mol Biol (Noisy-le-grand); 2016 Jun; 62(7):97-101. PubMed ID: 27453280
[TBL] [Abstract][Full Text] [Related]
10. The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway.
Heeg MH; Koziolek MJ; Vasko R; Schaefer L; Sharma K; Müller GA; Strutz F
Kidney Int; 2005 Jul; 68(1):96-109. PubMed ID: 15954899
[TBL] [Abstract][Full Text] [Related]
11. Aspirin alleviates cardiac fibrosis in mice by inhibiting autophagy.
Liu PP; Liu HH; Sun SH; Shi XX; Yang WC; Su GH; Zhao J
Acta Pharmacol Sin; 2017 Apr; 38(4):488-497. PubMed ID: 28216620
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of autophagy inhibits the conversion of cardiac fibroblasts to cardiac myofibroblasts.
Gupta SS; Zeglinski MR; Rattan SG; Landry NM; Ghavami S; Wigle JT; Klonisch T; Halayko AJ; Dixon IM
Oncotarget; 2016 Nov; 7(48):78516-78531. PubMed ID: 27705938
[TBL] [Abstract][Full Text] [Related]
13. Notch3 Ameliorates Cardiac Fibrosis After Myocardial Infarction by Inhibiting the TGF-β1/Smad3 Pathway.
Zhang M; Pan X; Zou Q; Xia Y; Chen J; Hao Q; Wang H; Sun D
Cardiovasc Toxicol; 2016 Oct; 16(4):316-24. PubMed ID: 26487518
[TBL] [Abstract][Full Text] [Related]
14. Palmatine alleviates cardiac fibrosis by inhibiting fibroblast activation through the STAT3 pathway.
Lin S; Zhang S; Zhan A; Feng J; Yang Q; Li T; Liu Z; Mo Q; Fan H; Wang K; Wang L
Eur J Pharmacol; 2024 Mar; 967():176395. PubMed ID: 38350592
[TBL] [Abstract][Full Text] [Related]
15. Relaxin Inhibits Cardiac Fibrosis in Diabetic Rats: Roles of Protein Kinase Cδ.
Wang P; Li M; Dong L; Chen H; Su W; Wang YP
Exp Clin Endocrinol Diabetes; 2018 May; 126(5):298-305. PubMed ID: 28895644
[TBL] [Abstract][Full Text] [Related]
16. LncRNA FAF inhibits fibrosis induced by angiotensinogen II via the TGFβ1-P-Smad2/3 signalling by targeting FGF9 in cardiac fibroblasts.
Sun J; Wang Z; Shi H; Gu L; Wang S; Wang H; Li Y; Wei T; Wang Q; Wang L
Biochem Biophys Res Commun; 2020 Jan; 521(3):814-820. PubMed ID: 31708099
[TBL] [Abstract][Full Text] [Related]
17. CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation.
Wu D; Lei H; Wang JY; Zhang CL; Feng H; Fu FY; Li L; Wu LL
J Mol Med (Berl); 2015 Dec; 93(12):1311-25. PubMed ID: 26138247
[TBL] [Abstract][Full Text] [Related]
18. Serelaxin treatment promotes adaptive hypertrophy but does not prevent heart failure in experimental peripartum cardiomyopathy.
Nonhoff J; Ricke-Hoch M; Mueller M; Stapel B; Pfeffer T; Kasten M; Scherr M; von Kaisenberg C; Bauersachs J; Haghikia A; Hilfiker-Kleiner D
Cardiovasc Res; 2017 May; 113(6):598-608. PubMed ID: 28453725
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol inhibits high glucose induced collagen upregulation in cardiac fibroblasts through regulating TGF-β1-Smad3 signaling pathway.
Liu J; Zhuo X; Liu W; Wan Z; Liang X; Gao S; Yuan Z; Wu Y
Chem Biol Interact; 2015 Feb; 227():45-52. PubMed ID: 25559857
[TBL] [Abstract][Full Text] [Related]
20. Metformin attenuates cardiac fibrosis by inhibiting the TGFbeta1-Smad3 signalling pathway.
Xiao H; Ma X; Feng W; Fu Y; Lu Z; Xu M; Shen Q; Zhu Y; Zhang Y
Cardiovasc Res; 2010 Aug; 87(3):504-13. PubMed ID: 20200042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
